stockrowSTERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.
- Revenue
- +8.79%
- EPS
- +12.8%
- Free cash flow
- +43.6%
- Total debt
- −0.21%
Quarter to September 2026, against a year earlier
Follow STE
Alert me
STERIS plc (STE) Total debt
STERIS plc's total debt at the end of fiscal 2026 was $1.9B, down 5.48% from $2.0B in fiscal 2025. At the end of the quarter to 30 September 2026 it was $1.9B. Over the past ten years it has ranged from $621.1M (fiscal 2015) to $3.2B (fiscal 2024); the current reading is higher than 67% of that period. STERIS plc ranks 11th of 147 Medical Devices companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2026 | $1.9B | (5.48%) |
| FY2025 | $2.0B | (36.26%) |
| FY2024 | $3.2B | 4.14% |
| FY2023 | $3.1B | (0.31%) |
| FY2022 | $3.1B | 84.54% |
| FY2021 | $1.7B | 42.97% |
| FY2020 | $1.2B | (1.07%) |
| FY2019 | $1.2B | (10.09%) |
| FY2018 | $1.3B | (10.98%) |
| FY2017 | $1.5B | (5.70%) |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $1.9B | (0.01%) |
| Jun 2026 | $1.9B | (1.97%) |
| Mar 2026 | $1.9B | 1.75% |
| Dec 2025 | $1.9B | 0.06% |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | $11.6B |
| PHG Koninklijke Philips N.V. compare | $8.0B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $7.5B |
| SNN Smith & Nephew SNATS, Inc. compare | $3.2B |
| STE STERIS plc | $1.9B |
| DXCM DexCom, Inc. compare | $1.2B |
| GMED Globus Medical, Inc. compare | $443.4M |
| GKOS Glaukos Corporation compare | $66.9M |
| PEN Penumbra, Inc. compare | $19.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on STE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement